The Present and Future Burden of Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) by Histology and Line of Therapy in France, Germany, Italy, and Spain: Model-Based Predictions

Population Health Metrics - United Kingdom
doi 10.1186/s12963-018-0174-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient Count Forecasts of Advanced Non-Small Cell Lung Cancer: Results From the UK, Germany, France, Italy and Spain (Eu-5)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.04-17 Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Atezolizumab for the First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): Current Status and Future Prospects

Frontiers in Oncology
Cancer ResearchOncology
2018English

Immunotherapy in Non-Small Cell Lung Cancer: The Past, the Present, and the Future

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Survival Analysis of Advanced Non–Small Cell Lung Cancer Patients Treated by Using Wheel Balance Cancer Therapy

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2016English

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Oncologist
Cancer ResearchMedicineOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy